Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
48.0%
% of BBH's 27 holdings also in PBE
42.9%
% of PBE's 28 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 14.1% | 6.7% | 6.7% |
|
AMGEN INC | 18.3% | 5.7% | 5.7% |
|
REGENERON PHARMACEUTICALS | 6.2% | 4.9% | 4.9% |
|
NATERA INC | 3.8% | 4.4% | 3.8% |
|
BIOGEN IDEC INC | 3.2% | 4.9% | 3.2% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to PBE
|
AMGEN INC | 12.5% |
|
VERTEX PHARMACEUTICALS INC | 12.0% |
|
GILEAD SCIENCES INC | 7.4% |
 |
ARGENX SE ADR | 4.9% |
|
IQVIA HOLDINGS INC | 4.3% |
|
ALNYLAM PHARMACEUTICALS INC | 3.7% |
 |
ICON PLC | 3.1% |
 |
BIONTECH SE SPONSORED ADR | 2.4% |
|
BEIGENE LTD. SPONSORED ADR | 2.3% |
|
INSMED INC | 2.1% |
BBH Underweight Relative to PBE
|
UNITED THERAPEUTICS CORP | -4.5% |
|
HALOZYME THERAPEUTICS INC | -3.6% |
|
AXSOME THERAPEUTICS, INC. | -3.6% |
|
ROYALTY PHARMA PLC CLASS A | -3.5% |
|
INCYTE CORP | -3.4% |
|
TG THERAPEUTICS INC | -3.1% |
|
ACADIA PHARMACEUTICALS INC | -3.0% |
|
EXELIXIS INC | -3.0% |
|
BIOCRYST PHARMACEUTICALS INC | -3.0% |
|
CATALYST PHARMACEUTICAL PART | -2.9% |